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Introduction
One of the important clinical decisions that must be made when 
caring for a person with diabetes is to determine if his or her 
blood glucose is well controlled. If the patient is uncontrolled, 
treatment intensification or behaviour change counselling 
is required. Many of the complications of diabetes can be 
mitigated or avoided by ensuring good glycaemic control.1 
Usually, this decision is made by means of a random blood 
glucose (RBG) test in the public sector. RBG is measured in the 
health centre by a nurse using a glucometer. The rule of thumb 
used by many practitioners is that a patient with a RBG of 
> 10 mmol/l is uncontrolled. However, guidelines recommend 
the use of glycated haemoglobin (HbA1c) to accurately assess 
control of blood glucose.2 An HbA1c of 7% or less is regarded 
as good control and the goal of treatment. In Cape Town, health 
workers were recently allowed to order one HbA1c test per year, 
per patient. Currently, approximately 40% of patients receive 
this test, and as it must be sent away to the laboratory, it is 
often not available at the time that a clinical decision needs to 
be taken.3
This study aimed to determine the validity of clinical decisions 
based on RBG, when compared to the results obtained by 
HbA1c, in a district hospital setting. 
The study was a retrospective analysis of existing hospital 
and laboratory data. A sample size of 350 was recommended 
to achieve 80% power to detect a correlation of at least 0.2, 
using a two-sided hypothesis test with a significance level of 
0.05. Data were obtained from the National Health Laboratory 
Service on HbA1c tests requested by Karl Bremer District 
Hospital in 2010. The patient records for each of the HbA1c test 
results were drawn, and the corresponding RBG obtained that 
was taken in the outpatient department at the same visit. 
Microsoft® Excel® was used to capture the quantitative 
data and Pearson’s product-moment correlation coefficient 
to evaluate the correlation between HbA1c and RBG, with 
Spearman’s rank correlation coefficient as an alternative for 
non-normally distributed data. A HbA1c level of ≤ 7% was taken 
to represent good control and > 7% poor control. The sensitivity, 
specificity, predictive values and likelihood ratios of different 
threshold levels of RBG were then analysed. In addition, the 
study population was also examined by means of a receiver 
operating characteristic (ROC) curve to determine the value of 
RBG with the best combination of sensitivity and specificity 
to predict poor control of diabetes. Statistica® version 9 was 
used to evaluate the data with the assistance of the Centre for 
Statistical Consultation.
Data were obtained on 349 patients with diabetes, of whom 
203 (58.2%) were female and 146 (41.8%) male. The study 
population had a mean age of 54.7 years (standard deviation 
15.2), mean RBG of 13 mmol/l, and mean HbA1c of 9.4%. Of 
this population, 247 (70.8%) were uncontrolled with an HbA1c 
> 7%. There was only a moderate, but significant correlation 
between the RBG and HbA1c results (correlation co-efficient 0.6, 
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Abstract
It is important to decide if a patient with diabetes has good glycaemic control in order to guide treatment and to offer behaviour 
change counselling. Currently, determining random blood glucose (RBG) is usually carried out in primary care in the public sector 
to make this decision. This study investigates the validity of these decisions. Retrospective data from a district hospital setting 
were used to analyse the correlation between glycated haemoglobin (HbA1c) and RBG, the best predictive value of RBG, and its 
predictive properties. The best value of RBG to predict control (HbA1c ≤ 7%) was 9.8 mmol/l. However, this threshold only gave a 
sensitivity of 77% and a specificity of 75%. Clinicians would be wrong 23% of the time when using RBG to determine glycaemic 
control. Attempts should be made to make HbA1c more available for clinical decision-making. Point-of-care testing for HbA1c should 
be considered.
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p-value < 0.001), which only explained 45% of the variation in 
RBG. The ROC shown in Figure 1 demonstrates that an RBG of 
9.8 mmol/l had the best predictive properties (Table I) to 
determine the control of diabetes.
If decisions are made on this basis, 23% of 70.8% of patients 
with poor control will be missed. It implies that of 100 patients 
seen in the outpatient department, 16 who are poorly controlled 
will be missed and have a RBG that is less than 9.8 mmol/l. 
On the other hand, 25% of the 29.2% of patients with good 
control will be inappropriately labelled as poorly controlled. This 
implies that of 100 patients, seven will fall into this category 
and will have an RBG of greater than 9.8 mmol/l when seen. 
Therefore, overall, a decision made on the basis of RBG would 
inappropriately categorise 23 of every 100 patients seen. Thus, 
currently, although decision-making using RBG is based on the 
best possible cut-off value, almost a quarter of patients would 
be mismanaged using this system.
In conclusion, the study highlights that a single RBG result 
should not be relied upon to make a valid decision about the 
control of diabetes. It is possible that the mean of a series of 
RBG results taken over time could have better validity. However, 
this is not current practice and would require a separate study. 
In view of the problems with the number of patients being 
tested, and doctors having access to the HbA1c result at the 
time that the clinical decision is taken, we recommend that 
point-of-care testing for HbA1c should be explored.
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Figure 1: Receiver operator characteristic curve for random blood 
glucose
Table I: Predictive properties of a random blood glucose 
threshold of 9.8 mmol/l
Indicator Result
Sensitivity 77%
Specificity 75%
Positive predictive value 0.88
Positive likelihood ratio 3.08
Prevalence of poor control 70.8%
Pretest odds 2.42
Post-test odds 7.45
Post-test probability 88.2%
